Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs

Veterinary Surgery

Volumn 27, Issue 2, 1998, Pages 159-166

  Egger, Christine M ^a   Duke, Tanya ^a   Archer, Joy ^a   Cribb, Peter H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; FEMALE; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SKIN;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; COHORT STUDIES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; MALE; SKIN;

EID: 0032013210     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-950X.1998.tb00114.x     Document Type: Review

References (32)

1. Calis KA, Kohler DR, Corso DM: Transdermally administered fentanyl for pain management. Clin Pharm 11:22-36, 1992
2. Gardocki JF, Yelnosky J: A study of some of the pharmacologic actions of fentanyl citrate. Toxicol Appl Pharmacol 6:48-62, 1964
3. Hug CC, Murphy MR: Fentanyl disposition in cerebrospinal fluid and plasma and its relationship to ventilatory depression in the dog. Anesthesiology 50:342-349, 1979
4. Cartwright P, Prys-Roberts C, Gill K, et al: Ventilatory depression related to plasma fentanyl concentrations during and after anesthesia in humans. Anesth Analg 62:966-974, 1983
5. Andrews CJH, Sinclair M, Prys-Roberts C, et al: Ventilatory effects during and after continuous infusion of fentanyl or alfentanil. Br J Anaesth 55:211S-216S, 1983
6. Holley FO, Van Steennis C: Postoperative analgesia with fentanyl: Pharmacokinetics and pharmacodynamics of constant-rate I.V. and transdermal delivery. Br J Anaesth 60:608-613, 1988
7. Gourlay GK, Kowalski SR, Plummer JL, et al: The transdermal administration of fentanyl in the treatment of postoperative pain: Pharmacokinetics and pharmacodynamic effects. Pain 37:193-202, 1989
8. Varvel JR, Shafer SL, Hwang SS, et al: Absorption characteristics of transdermally administered fentanyl. Anesthesiology 70:928-934, 1989
9. 3H-fentanyl in the dog anesthetized with enflurane. Anesthesiology 50:13-19, 1979
10. Kyles AE, Papich M, Hardie EM: Disposition of transdermally administered fentanyl in dogs. Am J Vet Res 57:715-719, 1996
11. McClain DA, Hug CC: Intravenous fentanyl kinetics. Clin Pharmacol Ther 28:106-114, 1980
12. Roy SD, Hou E, Witham SL, et al: Transdermal delivery of narcotic analgesics: Comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J Pharm Sci 83:1723-1728, 1994
13. Janssen Pharmaceutica: Duragesic package insert. Piscataway, NJ, Janssen Pharmaceutica, 1991
14. Hardie EM: New horizons in pain management: Transdermal fentanyl patches. Perspectives Jan/Feb: 35-55, 1995
15. Scherk-Nixon M: A study of the use of a transdermal fentanyl patch in cats. J Am Anim Hosp Assoc 32:19-24, 1996
16. Schultheiss PJ, Morse BC, Baker WH: Evaluation of a transdermal fentanyl system in the dog. Contemp Top Vet Med 34:75-81, 1995
17. Michiels M, Hendriks R, Heykants J: A sensitive radioimmunoassay for fentanyl plasma level in dogs and man. Eur J Clin Pharmacol 12:153-158, 1977
18. Schuttler J, White PF: Optimization of the radioimmunoassays for measuring fentanyl and alfentanil in human serum. Anesthesiology 61:315-320, 1984
19. Shargel L, Yu ABC: Applied Biopharmaceutics and Pharmacokinetics (ed 3). Toronto, Appleton & Lange, 1993
20. Plezia PM, Kramer TH, Linford J, et al: Transdermal fentanyl: Pharmacokinetics and preliminary clinical evaluation. Pharmacotherapy 9:2-9, 1989
21. Gourlay GK, Kowalski SR, Plummer JL, et al: The efficacy of transdermal fentanyl in the treatment of postoperative pain: A double-blind comparison of fentanyl and placebo systems. Pain 40:21-28, 1990
22. Sandler AN, Baxter AD, Katz J, et al: A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Anesthesiology 81:1169-1180, 1994
23. Roy SD, Flynn GL: Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharmacol Res 7:842-847, 1990
24. Rose PG, Macfee MS, Boswell MV: Fentanyl transdermal system overdose secondary to cutaneous hyperthermia. Anesth Analg 77:390-391, 1993
25. Duthie DJR, McLaren AD, Nimmo WS: Pharmacokinetics of fentanyl during constant rate IV infusion for the relief of pain after surgery. Br J Anaesth 58:950-956, 1986
26. Murphy MR, Hug CC, McClain DA: Dose-independent pharmacokinetics of fentanyl. Anesthesiology 59:537-540, 1983
27. Yee LY, Lopez JR: Transdermal fentanyl. Ann Pharmacother 26:1393-1399, 1992
28. Woestenborghs RJH, Stanski DR, Scott JC, et al: Assay methods for fentanyl in serum: Gas-liquid chromatography versus radioimmunoassay. Anesthesiology 67:85-90, 1987
29. Duthie DJR, Rowbotham DJ, Wyld R, et al: Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. Br J Anaesth 60:614-618, 1988
30. Holdiness MR: A review of contact dermatitis associated with transdermal therapeutic systems. Contact Dermatitis 20:3-9, 1989
31. Murphy MR, Hug CC: The anesthetic potency of fentanyl in terms of its reduction of enflurane MAC. Anesthesiology 57:485-488, 1982
32. Arndt JO, Mikat M, Parasher C: Fentanyl's analgesic, respiratory, and cardiovascular actions in relation to dose and plasma concentration in unanesthetized dogs. Anesthesiology 61:355-361, 1984